Death by a thousand cuts: the slow demise of chemotherapy

Affiliations

Free article

Editorial

Ajay K Nooka et al. Cancer. 2016.

Free article

. 2016 Jul 1;122(13):1971-3.

doi: 10.1002/cncr.30024. Epub 2016 May 18.

¹ Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

No abstract available

Comment on

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.
Orlowski RZ, Nagler A, Sonneveld P, Bladé J, Hajek R, Spencer A, Robak T, Dmoszynska A, Horvath N, Spicka I, Sutherland HJ, Suvorov AN, Xiu L, Cakana A, Parekh T, San-Miguel JF. Orlowski RZ, et al. Cancer. 2016 Jul 1;122(13):2050-6. doi: 10.1002/cncr.30026. Epub 2016 May 18. Cancer. 2016. PMID: 27191689 Free PMC article. Clinical Trial.